TINCR and lung adenocarcinoma: Finally, we studied the potential tumor suppressor activity of pTINCR in other epithelial cancers and observed that high expression of TINCR significantly correlates with increased overall survival (OS) of patients with bladder carcinoma (Log rank test p = 0.00034, HR = 0.59), PDAC (Log rank test p = 0.0024, HR = 0.51), stomach adenocarcinoma (Log rank test p = 0.022, HR = 0.63), head and neck squamous cell carcinoma (Log rank test p = 0.0022, HR = 0.66) and lung adenocarcinoma (Log rank test p = 0.021, HR = 0.7) (Fig. 7g).